Shi‐Ming Lin

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Long–Term Beneficial Effect of Interferon Therapy in Patients With Chronic Hepatitis B Virus Infection

Shi‐Ming Lin, I-Shyan Sheen, Rong‐Nan Chien et al. · Hepatology · 1999 · 450 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Shi‐Ming Lin, Ming‐Lung Yu, Chuan–Mo Lee et al. · Journal of Hepatology · 2006 · 309 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk

Ming‐Whei Yu, H. C. Chang, Shun‐Chiao Chang et al. · Hepatology · 2003 · 176 citations

Medicine, Endocrinology, Oncology +15

Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus

Jann‐Tay Wang, T. H. Wang, Jin‐Chuan Sheu et al. · Journal of Clinical Microbiology · 1992 · 133 citations · Full text

Medicine, Infectious Diseases, Molecular Medicine +15